{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:33:27Z","timestamp":1740144807450,"version":"3.37.3"},"reference-count":24,"publisher":"American Diabetes Association","issue":"1","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The prevalence of pregnancies affected by diabetes is increasing, with the Centers for Disease Control and Prevention reporting that 1\u20132% of pregnant women have type 1 or type 2 diabetes and up to 10% of pregnancies are affected by gestational diabetes as of 2018. Maternal glycemic management is directly related to fetal and neonatal outcomes, and aberrant maternal hyperglycemia has known negative outcomes. Although most of glycemic management centers on outpatient treatment, evidence exists to support the use of intravenous insulin drips during inpatient admissions. This study aimed to evaluate an intravenous insulin protocol specific to the obstetric (OB) population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research Design and Methods<\/jats:title>\n                  <jats:p>This was a single-center retrospective pre-\/post- cohort study of OB patients with diabetes admitted to an academic medical center. Groups were differentiated based on admission date and protocol implementation with a 6-month washout period. Included patients received an intravenous insulin drip around either antenatal corticosteroid administration or during labor and delivery. Those who were within 7 days of receiving a diabetic ketoacidosis diagnosis or who were admitted to an intensive care unit were excluded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifty-nine patients received 69 distinct insulin drip orders. Twelve drips were included in the group admitted before initiation of the insulin drip protocol (pre-group) and 57 in the group admitted after the protocol went into effect (post-group). Time spent within the goal glucose range while on an insulin drip in the pre-group was 1.63% compared with 39.30% in the post-group (P &amp;lt;0.001). Glucose levels &amp;lt;70 mg\/dL was 0.00% in the pre-group compared with 3.23% in the post-group (P = 0.045). There were no differences in severe hypoglycemia (glucose &amp;lt;50 mg\/dL), hyperglycemia (glucose &amp;gt;110 mg\/dL), or neonatal outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Implementation of a nursing-driven, obstetrics-specific intravenous insulin drip protocol significantly improved maternal glycemic management within a goal glucose range of 70\u2013110 mg\/dL during antenatal corticosteroid administration and labor and delivery.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/ds24-0011","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T18:26:08Z","timestamp":1726683968000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of a Standardized Obstetrics Insulin Drip Protocol and Order Set"],"prefix":"10.2337","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1720-084X","authenticated-orcid":false,"given":"Margaret","family":"Davis","sequence":"first","affiliation":[{"name":"1Department of Pharmacy, University of Kentucky HealthCare \u2013 Kentucky Children\u2019s Hospital, Lexington, KY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4738-3785","authenticated-orcid":false,"given":"Kristina","family":"Naseman","sequence":"additional","affiliation":[{"name":"2Department of Pharmacy, University of Kentucky HealthCare, Lexington, KY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelle","family":"Leung","sequence":"additional","affiliation":[{"name":"1Department of Pharmacy, University of Kentucky HealthCare \u2013 Kentucky Children\u2019s Hospital, Lexington, KY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aric","family":"Schadler","sequence":"additional","affiliation":[{"name":"3University of Kentucky HealthCare \u2013 Kentucky Children\u2019s Hospital, Lexington, KY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"2025021419514686200_B1","first-page":"1","article-title":"Trends and characteristics in gestational diabetes: United States, 2016\u20132020","volume":"71","author":"Gregory","year":"2022","journal-title":"Natl Vital Stat Rep"},{"key":"2025021419514686200_B2","doi-asserted-by":"crossref","first-page":"e14744","DOI":"10.1111\/dme.14744","article-title":"Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes: an updated guideline from the Joint British Diabetes Society for Inpatient Care","volume":"39","author":"Dashora","year":"2022","journal-title":"Diabet Med"},{"key":"2025021419514686200_B3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11892-018-1054-9","article-title":"Glucose targets and insulin choice in pregnancy: what has changed in the last decade?","volume":"18","author":"Bacon","year":"2018","journal-title":"Curr Diab Rep"},{"key":"2025021419514686200_B4","doi-asserted-by":"crossref","first-page":"592522","DOI":"10.3389\/fendo.2020.592522","article-title":"Observations on glucose excursions with the use of a simple protocol for insulin, following antenatal betamethasone administration","volume":"11","author":"Paulsen","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025021419514686200_B5","doi-asserted-by":"crossref","first-page":"e14489","DOI":"10.1111\/dme.14489","article-title":"Efficacy and safety of the pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in type 1 and type 2 diabetes","volume":"38","author":"Rowe","year":"2021","journal-title":"Diabet Med"},{"key":"2025021419514686200_B6","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1210\/jc.2005-0007","article-title":"Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in Pima Indian children","volume":"90","author":"Bunt","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2025021419514686200_B7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1067\/mob.2001.114918","article-title":"Perinatal outcomes in gestational diabetes: a comparison of criteria for diagnosis","volume":"184","author":"Pennison","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"2025021419514686200_B8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1464-5491.2005.01434.x","article-title":"Birthweight and other pregnancy outcomes in a cohort of women with pre-gestational insulin-treated diabetes mellitus, Scotland, 1979\u201395","volume":"22","year":"2005","journal-title":"Diabet Med"},{"key":"2025021419514686200_B9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2337\/diacare.18.5.611","article-title":"Impaired glucose tolerance in adolescent offspring of diabetic mothers: relationship to fetal hyperinsulinism","volume":"18","author":"Silverman","year":"1995","journal-title":"Diabetes Care"},{"key":"2025021419514686200_B10","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1097\/AOG.0000000000002960","article-title":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics. ACOG practice bulletin no. 201: pregestational diabetes mellitus","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2025021419514686200_B11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/OGX.0000000000000671","article-title":"Pharmacologic treatment of diabetes in pregnancy","volume":"74","author":"Bishop","year":"2019","journal-title":"Obstet Gynecol Surv"},{"key":"2025021419514686200_B12","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00125-019-4943-9","article-title":"Factors associated with stillbirth in women with diabetes","volume":"62","author":"Mackin","year":"2019","journal-title":"Diabetologia"},{"key":"2025021419514686200_B13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/dme.13674","article-title":"Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes","volume":"35","author":"Dashora","year":"2018","journal-title":"Diabet Med"},{"key":"2025021419514686200_B14","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1080\/14767058.2021.1900104","article-title":"Comparison of a subcutaneous versus intravenous insulin protocol for managing hyperglycemia following antenatal betamethasone in women with diabetes: a pilot randomized controlled trial","volume":"35","author":"Sweeting","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025021419514686200_B15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bpobgyn.2010.10.002","article-title":"Insulin during pregnancy, labour and delivery","volume":"25","author":"de Valk","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025021419514686200_B16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11892-018-1045-x","article-title":"Inpatient glycemic management of the pregnant patient","volume":"18","author":"Yeh","year":"2018","journal-title":"Curr Diab Rep"},{"key":"2025021419514686200_B17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/AOG.0000000000003940","article-title":"Evaluation of an intrapartum insulin regimen for women with diabetes","volume":"136","author":"Dude","year":"2020","journal-title":"Obstet Gynecol"},{"key":"2025021419514686200_B18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11892-013-0457-x","article-title":"Inpatient management of women with gestational and pregestational diabetes in pregnancy","volume":"14","author":"Garrison","year":"2014","journal-title":"Curr Diab Rep"},{"key":"2025021419514686200_B19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4158\/EP.10.S2.71","article-title":"Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy","volume":"10","author":"Bode","year":"2004","journal-title":"Endocr Pract"},{"key":"2025021419514686200_B20","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.2337\/dc24-S015","article-title":"15. Management of diabetes in pregnancy: Standards of Care in Diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"2025021419514686200_B21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/HAB-190385","article-title":"Comparison between the effect of regular human insulin and NPH with novo-rapid and levemir insulin in glycemic control in gestational diabetes","volume":"27","author":"Amini","year":"2019","journal-title":"Hum Antibodies"},{"key":"2025021419514686200_B22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/dme.12740","article-title":"Clinical outcomes of adult inpatients treated with continuous subcutaneous insulin infusion for diabetes mellitus: a systematic review","volume":"32","author":"Anstey","year":"2015","journal-title":"Diabet Med"},{"key":"2025021419514686200_B23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ajog.2006.05.051","article-title":"Intrapartum maternal glycemic control in women with insulin requiring diabetes: a randomized clinical trial of rotating fluids versus insulin drip","volume":"195","author":"Rosenberg","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"2025021419514686200_B24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1055\/s-0038-1629903","article-title":"Management of diabetes in the intrapartum and postpartum patient","volume":"35","author":"Dude","year":"2018","journal-title":"Am J Perinatol"}],"container-title":["Diabetes Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/spectrum\/article-pdf\/doi\/10.2337\/ds24-0011\/783126\/diaspectds240011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/spectrum\/article-pdf\/doi\/10.2337\/ds24-0011\/783126\/diaspectds240011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T19:51:58Z","timestamp":1739562718000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/spectrum\/article\/38\/1\/68\/157254\/Evaluation-of-a-Standardized-Obstetrics-Insulin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,9,18]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/ds24-0011","relation":{},"ISSN":["1040-9165","1944-7353"],"issn-type":[{"type":"print","value":"1040-9165"},{"type":"electronic","value":"1944-7353"}],"subject":[],"published":{"date-parts":[[2024,9,18]]}}}